Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0042109 (
urticaria
)
6,569
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A 21
-year-old man experienced persistent swelling of his lips and generalized pruritus without
hives
associated with swimming. Provocative testing with tap water produced transient edema and pruritus. Sweating and methacholine testing did not produce cholinergic
urticaria
. After several weeks, the angioedema gradually subsided, the reaction to tap water became negative, and the patient was able to swim again without reactions. Water should be added to the list of physical agents that cause angioedema as well as
urticaria
.
...
PMID:Aquagenic angioedema. 372 Mar 54
A 21
-year-old woman developed an erythematous papulovesicular eruption of photo-exposed sites, following the use of an oxybenzone-containing sunscreen. Patch testing, photopatch testing, phototesting, and histology produced findings strongly suggestive of oxybenzone photoallergy. Photopatch testing with a monochromator source showed abnormal UVA responses, with evidence of immediate
urticaria
, and delayed-onset dermatitis. Sun-barrier use is associated with a risk of the development of contact or photocontact allergic reactions. The benzophenones are frequently used in high-protection factor sun-barrier preparations, and appear to have a particular ability to induce such responses.
...
PMID:Photoallergic contact dermatitis to oxybenzone. 804 4
We analyzed the alarm pheromone components from five colonies of Africanized honeybees and three colonies of European honeybees collected in Mexico. Analyses revealed a novel alarm pheromone component that was only present in appreciable quantities in the Africanized bee samples. Analysis of the mass spectrum and subsequent synthesis confirmed that this compound is 3-methyl-2-buten-1-yl acetate (3M2BA), an unsaturated derivative of
IPA
. In Africanized honeybees, sampling from stings of guards showed that 3M2BA was present at levels of 0-38% the amount of isoamyl acetate (
IPA
). Behavioral assays from three colonies each of Africanized and European bees showed that 3M2BA recruited worker bees from
hives
of both Africanized bees and European bees at least as efficiently as isopentyl acetate
IPA
, a compound widely reported to have the highest activity for releasing alarm and stinging behavior in honeybees. However, a mixture of of 3M2BA and
IPA
(1:2) recruited bees more efficiently than either of the compounds alone. None of the compounds differed in their efficacy for inducing bees to pursue the observers.
...
PMID:Discovery of 3-methyl-2-buten-1-yl acetate, a new alarm component in the sting apparatus of Africanized honeybees. 1273 69
A 21
-month-old boy developed
urticaria
multiforme during the course of a presumed pneumonia, which was treated with imacillin. At admission to hospital he was initially considered to have erythema multiforme, but the correct diagnosis was soon established as
urticaria
multiforme. He had a good response to antihistamines. The diagnostic differences between
urticaria
multiforme and erythema multiforme are presented in this case report.
...
PMID:[Urticaria multiforme is a variation of urticaria, which imitates erythema multiforme]. 2340 56
A 21
-year-old male patient with no history of systemic disease or drug use presented to our clinic with redness and pain in the right eye. Best corrected visual acuity was 20/20 in both eyes. Inflamed pinguecula was observed on slit-lamp examination and the patient was prescribed ophthalmic nepafenac eye drops. After instilling the drops that day and the next day, the patient presented again due to pruritus and rash. Upon consultation with the dermatology department, the patient was diagnosed with drug-induced allergic urticaria and the nepafenac drops were discontinued. Although
urticaria
has been reported as a side effect after systemic non-steroidal anti-inflammatory drug (NSAID) use, such a reaction has not been reported with an ophthalmic NSAID and ours is the first reported case of
urticaria
following ophthalmic nepafenac use. This unique case highlights the fact that ophthalmologists must also keep
urticaria
in mind as a potential side effect when prescribing this drug.
...
PMID:A Case of Allergic Urticaria After Ophthalmic Nepafenac Use. 2998 79